CoChat

Chronic benzodiazepine treatment decreases postsynaptic GABA sensitivity

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Abstract

Benzodiazepines exert most of their pharmacological effects by a selective facilitation of the postsynaptic actions of GABA. Clinical, behavioural and electrophysiological studies have shown reduced drug response following chronic benzodiazepine administration. We present here electrophysiological evidence for decreased postsynaptic sensitivity to GABA following chronic benzodiazepine administration as measured by the direct iontophoretic application of GABA and serotonin onto serotonergic cells in the midbrain dorsal raphe nucleus (DRN), known to receive GABAergic input. The subsensitivity to GABA was found to be dose dependent and was seen when diazepam administration was three weeks or longer. Further, acute injection of the specific benzodiazepine antagonist, Ro15-1788, was found to reverse rapidly the decrease in GABA sensitivity observed in chronically diazepam-treated animals without altering GABA sensitivity in vehicle-treated rats. Decreased response to chronic benzodiazepines does not appear to be consistently related to alterations in the number or affinity of receptors for benzodiazepines. Our studies of radioligand-binding showed a decrease in the ability of GABA to enhance benzodiazepine binding in cerebral cortical membranes from chronic diazepam-treated animals without significant changes in benzodiazepine binding site density or affinity.

Overview

Integrity signals

Registry

Crossref · 10.1038/308074a0

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 26 references

Research works printed but not linked: 8

  1. Haefely, W. et al. In GABA-Neurotransmitters (eds Krogsgaard-Larsen, P., Scheel-Krueger, J. & Kofod H.) 357–375 (Munksgaard, Copenhagen, 1979).
  2. Browne, T. R., In Pharmacology of Benzodiazepines (eds Usdin, E., Skolnick, P., Tallman, J., Greenblatt, D. & Paul, S.) 329–337 (Macmillan, London, 1983).
  3. Waterhouse, B., Moises, H., Yeh, H., Geller, H. & Woodward, D. J. Pharmac. exp. Ther. (in the press).
  4. McNicholas, L. & Martin, W. Fedn Proc. 41, 1639 (1982).
  5. Gallager, D. & Tallman, J. Neuropharmacology (in the press).
  6. Braestrup, C. & Nielsen, M. Adv. Biosci. 31, 221–227 (1981).
  7. Costa, E., Corda, M., Epstein, B., Forchetti, C. & Guidotti, A. In Benzodiazepines: Molecular Biology to Clinical Practice (ed. Costa, E.) 117–146 (Raven, New York, 1983).
  8. Olsen, R. W. A. Rev. Pharmac. Tox. 22, 45–77 (1982).

Cited by

Items 201–278 of 278

Metadata

Authors
Gallager, D. W., Lakoski, J. M., Gonsalves, S. F., & Rauch, S. L.
Affiliations
Yale University (US)
Venue
Nature
Published
1984-03
Volume
308
Issue
5954
Pages
74-77
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W2076076801
Cited by
280
References
26
Citations by year
2026: 2 · 2025: 1 · 2024: 1 · 2023: 3 · 2022: 1 · 2021: 2 · 2019: 3 · 2018: 5 · 2017: 2 · 2016: 4 · 2015: 4 · 2013: 1 · 2012: 7
FWCI
7.59
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Nature (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords
diazepam, GABAergic inhibition, dorsal raphe nucleus, serotonergic neurons, Ro 15-1788, benzodiazepine antagonists, benzodiazepine binding, tolerance (pharmacology and immunology), cerebral cortex
MeSH terms
Action Potentials, Animals, Benzodiazepines, Brain Stem, Diazepam, Drug Antagonism, Flunitrazepam, gamma-Aminobutyric Acid, Male, Neurons, Raphe Nuclei, Rats, Inbred Strains, Receptors, Cell Surface, Receptors, GABA-A, Serotonin, Synapses, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.